LOADING
Tag: BioSpace
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – BioSpace
September 19, 2025
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
chat_bubble0 Comment
visibility80 Views
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study – BioSpace
September 5, 2025
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace Source link
chat_bubble0 Comment
visibility76 Views
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced – BioSpace
June 25, 2025
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced BioSpace Source link
chat_bubble0 Comment
visibility101 Views
Hand Eczema Market to Reach USD 29.2 Billion by 2035, Impelled by the Development of New and More Effective Treatments, Including Biologics, Corticosteroids, and Topical Therapies – BioSpace
February 1, 2025
Hand Eczema Market to Reach USD 29.2 Billion by 2035, Impelled by the Development of New and More Effective Treatments, Including Biologics, Corticosteroids, and Topical Therapies BioSpace Source link
chat_bubble0 Comment
visibility136 Views